2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European …

O Chioncel, M Adamo, M Nikolaou… - European Journal of …, 2023 - Wiley Online Library
Acute heart failure (AHF) represents a broad spectrum of disease states, resulting from the
interaction between an acute precipitant and a patient's underlying cardiac substrate and …

Cardiogenic shock in older adults: a focus on age-associated risks and approach to management: a scientific statement from the American heart Association

V Blumer, MK Kanwar, CF Barnett, JA Cowger… - Circulation, 2024 - Am Heart Assoc
Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates
of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for …

Demographics, procedural characteristics, and clinical outcomes when cardiogenic shock precedes TAVR in the United States

L Masha, S Vemulapalli, P Manandhar, P Balan… - Cardiovascular …, 2020 - jacc.org
Objectives This paper details trends and outcomes in US patients undergoing transcatheter
aortic valve replacement (TAVR) who present pre-procedurally with cardiogenic shock …

Coronary revascularization in patients undergoing aortic valve replacement for severe aortic stenosis

KP Patel, M Michail, TA Treibel, K Rathod… - Cardiovascular …, 2021 - jacc.org
Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist, with up to two
thirds of patients with AS having significant CAD. Given the challenges when both disease …

Management of valvulopathies with acute severe heart failure and cardiogenic shock

M Akodad, G Schurtz, J Adda, F Leclercq… - Archives of …, 2019 - Elsevier
Cardiogenic shock is a critical clinical situation, requiring rapid diagnosis, aetiological
assessment and immediate initiation of therapy. In industrialized countries, aortic stenosis is …

Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías: Desarrollada por el Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) y …

A Vahanian, F Beyersdorf, F Praz, M Milojevic… - Revista española de …, 2022 - Elsevier
Abstract The True Infection Rate (TIR) in the whole population of each country and the
Infection Fatality Rate (IFR) for coronavirus disease 2019 (COVID-19) are unknown although …

Emergency transcatheter aortic valve implantation for acute heart failure due to severe aortic stenosis in critically ill patients with or without cardiogenic shock

J Steffen, A Stocker, C Scherer, M Haum… - … Heart Journal: Acute …, 2022 - academic.oup.com
Aims Severe aortic stenosis can cause acute heart failure and cardiogenic shock (CS).
Transcatheter aortic valve implantation (TAVI) is the standard therapy for aortic stenosis in …